期刊
AMERICAN JOURNAL OF TRANSPLANTATION
卷 5, 期 7, 页码 1635-1645出版社
WILEY
DOI: 10.1111/j.1600-6143.2005.00913.x
关键词
assessment; cellular composition; diabetes; human islets; potency; transplantation; viability; beta-cell
资金
- NCRR NIH HHS [M01RR16587, 5U42RR016603, 1U42RR016603] Funding Source: Medline
- NIDDK NIH HHS [R03 DK075487, 1R01-DK55347] Funding Source: Medline
Current methodologies to evaluate islet cell viability are largely based on tests that assess the exclusion of DNA-binding dyes. While these tests identify cells that have lost selective membrane permeability, they do not allow us to recognize apoptotic cells, which do not yet stain with DNA-binding dyes. Furthermore, current methods of analysis do not discriminate between cell subsets in the preparation and, in particular, they do not allow for selectively defining beta-cell viability. For these reasons we have developed novel methods for the specific assessment of beta-cell content and viability in human islets based on cellular composition analysis through laser scanning cytometry (LSC) coupled with identification of beta-cell-specific apoptosis at the mitochondrial level. Our novel analytical methods hold promise to prospectively analyze clinical islet transplantation preparations and predict functional performance, as suggested by the observed correlation with in vivo analysis of islet potency in immunodeficient rodents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据